2020
DOI: 10.1007/s10096-020-03845-4
|View full text |Cite
|
Sign up to set email alerts
|

Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

7
35
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 39 publications
(44 citation statements)
references
References 24 publications
7
35
1
Order By: Relevance
“…Among the ve genes which were detected by multiplex PCR, the most encountered gene was OXA-48like at a genotypic frequency of 36.4%. This corroborates well with recent studies which documented OXA-48-like gene and its variants as the most prevalent genes [27,31,33,35]. OXA-48.…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…Among the ve genes which were detected by multiplex PCR, the most encountered gene was OXA-48like at a genotypic frequency of 36.4%. This corroborates well with recent studies which documented OXA-48-like gene and its variants as the most prevalent genes [27,31,33,35]. OXA-48.…”
Section: Discussionsupporting
confidence: 93%
“…and 89% to Ertapenem [30,31]. In comparison with previous studies at MNRH [23] and MBRRH [25] this study shows that the prevalence of carbapenem resistance in Uganda is on the rise and this is terrifying as recent meta-analyses revealed a substantial correlation between carbapenem resistant infections and increased risk of death [32].…”
Section: Discussionsupporting
confidence: 43%
See 1 more Smart Citation
“…This genotypic carbapenem resistance prevalence corroborates with earlier studies conducted in the East African region [18,25,38] and elsewhere [27,39] that reported levels ranging from 25% to 40%. Contrary, this frequency is signi cantly lower than carbapenem genotypic levels reported by studies in Tunisia (76.7%) [40], South Africa (68% and 86%) [33,34] , Egypt (89.6%) [37], Turkey (49.5%) [41]. KPC, VIM, NDM, OXA-48 and IMP are the commonest carbapenemases worldwide [42].…”
Section: Discussionmentioning
confidence: 77%
“…For example, prevalence of carbapenem resistance in Tanzania was 24% [25], Nigeria 15.2%, 27.4% and 36.8%) [26][27][28], India 31.77% [29]. Contrary, this frequency is higher than carbapenem resistance levels reported in countries like Ghana (7.2%) [30], Morocco 5.99% [31], and Ethiopia 2.73%, [32] with similar healthcare settings but lower than the incidences above 50% reported in South Africa, Egypt and Tunisia [33][34][35][36][37].…”
Section: Discussionmentioning
confidence: 91%